Cargando…
Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421105/ https://www.ncbi.nlm.nih.gov/pubmed/34509182 http://dx.doi.org/10.1016/j.ccell.2021.09.001 |
| _version_ | 1783749011221512192 |
|---|---|
| author | Greenberger, Lee M. Saltzman, Larry A. Senefeld, Jonathon W. Johnson, Patrick W. DeGennaro, Louis J. Nichols, Gwen L. |
| author_facet | Greenberger, Lee M. Saltzman, Larry A. Senefeld, Jonathon W. Johnson, Patrick W. DeGennaro, Louis J. Nichols, Gwen L. |
| author_sort | Greenberger, Lee M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8421105 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84211052021-09-07 Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies Greenberger, Lee M. Saltzman, Larry A. Senefeld, Jonathon W. Johnson, Patrick W. DeGennaro, Louis J. Nichols, Gwen L. Cancer Cell Letter Elsevier Inc. 2021-10-11 2021-09-07 /pmc/articles/PMC8421105/ /pubmed/34509182 http://dx.doi.org/10.1016/j.ccell.2021.09.001 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Greenberger, Lee M. Saltzman, Larry A. Senefeld, Jonathon W. Johnson, Patrick W. DeGennaro, Louis J. Nichols, Gwen L. Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title | Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title_full | Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title_fullStr | Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title_full_unstemmed | Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title_short | Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies |
| title_sort | anti-spike antibody response to sars-cov-2 booster vaccination in patients with b cell-derived hematologic malignancies |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421105/ https://www.ncbi.nlm.nih.gov/pubmed/34509182 http://dx.doi.org/10.1016/j.ccell.2021.09.001 |
| work_keys_str_mv | AT greenbergerleem antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies AT saltzmanlarrya antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies AT senefeldjonathonw antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies AT johnsonpatrickw antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies AT degennarolouisj antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies AT nicholsgwenl antispikeantibodyresponsetosarscov2boostervaccinationinpatientswithbcellderivedhematologicmalignancies |